Next Article in Journal
C7a, a Biphosphinic Cyclopalladated Compound, Efficiently Controls the Development of a Patient-Derived Xenograft Model of Adult T Cell Leukemia/Lymphoma
Next Article in Special Issue
Adenovirus Recruits Dynein by an Evolutionary Novel Mechanism Involving Direct Binding to pH-Primed Hexon
Previous Article in Journal
Anti-Apoptotic Effect of Tax: An NF-κB Path or a CREB Way?
Previous Article in Special Issue
Alphaherpesviruses and the Cytoskeleton in Neuronal Infections
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Herpesviruses and Intermediate Filaments: Close Encounters with the Third Type

Center for Immunobiology and Vaccine Development, Children’s Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA
Viruses 2011, 3(7), 1015-1040; https://doi.org/10.3390/v3071015
Submission received: 2 February 2011 / Revised: 7 June 2011 / Accepted: 24 June 2011 / Published: 4 July 2011
(This article belongs to the Special Issue Cytoskeleton in Viral Infections)

Abstract

:
Intermediate filaments (IF) are essential to maintain cellular and nuclear integrity and shape, to manage organelle distribution and motility, to control the trafficking and pH of intracellular vesicles, to prevent stress-induced cell death, and to support the correct distribution of specific proteins. Because of this, IF are likely to be targeted by a variety of pathogens, and may act in favor or against infection progress. As many IF functions remain to be identified, however, little is currently known about these interactions. Herpesviruses can infect a wide variety of cell types, and are thus bound to encounter the different types of IF expressed in each tissue. The analysis of these interrelationships can yield precious insights into how IF proteins work, and into how viruses have evolved to exploit these functions. These interactions, either known or potential, will be the focus of this review.

1. Introduction

Intermediate filaments (IF) constitute the third main cytoskeletal system of vertebrate cells. They not only provide structural and mechanical support to the cell, but are also involved in multiple cellular functions, including transport, protein and organelle targeting, migration, signaling, apoptosis, and protection from stress [1,2,3,4]. Because of this, IF are likely to play essential roles in enabling or restricting pathogen infection, and have the potential to become useful targets for new antiviral therapies. The dissection of IF-virus interactions could also provide crucial insights into the molecular mechanisms underlying the more than 80 human IF-linked diseases, and into the workings of cellular processes with the potential to be exploited therapeutically, such as the intracellular trafficking and delivery of cargoes. Compared to our knowledge of how viruses utilize the other two cytoskeletal components, the microfilaments (MF) and microtubules (MT), however, our current understanding of IF-virus interactions is largely incomplete. This review will focus on the interrelationships between human herpesviruses and IF during virion entry and egress, and during viral genome replication.

1.1. IF: An Overview

With an average diameter of 10 nm, IF owe their name to being of “intermediate” size between MF (6 nm in diameter) and MT (25 nm in diameter). Numerous types of IF are formed by the assembly of different polypeptides, displaying common structural domains but distinct expression profiles (Table 1). Because of their tissue-specific functions, the 70 currently known human IF proteins have been associated with a number of pathologies affecting various organs including the skin (e.g., epidermolysis bullosa simplex), the heart (e.g., dilated cardiomyopathy), the cornea (e.g., cataract), muscles (e.g., muscular dystrophy) and neurons (e.g., Charcot-Marie-Tooth disease) [4,5].
IF monomers consist of an alpha-helical rod flanked, at each end, by globular domains. Monomer dimerization is followed by the formation of tetramers via dimer association in antiparallel orientation, a setting that gives rise to smooth filaments devoid of polarity [6,7,8]. The polymerization of soluble, nucleotide-bound actin or tubulin, by contrast, generates polarized filaments possessing a plus end, to which subunits are added, and a minus end, from which subunits can be removed in a process known as treadmilling [9,10]. In contrast to MF and MT, IF assembly: (i) occurs spontaneously and in the absence of ATP or GTP [6,7,8,11]; (ii) does not depend on nucleotide availability or on the presence of cofactors and regulators, albeit new proteins facilitating IF polymerization have recently been identified [12]; (iii) is primarily, although not exclusively, regulated by phosphorylation [13]; and (iv) cannot be blocked by any currently available pharmaceutical compound.
IF are durable, stable and remarkably more resistant to breakage than MF and MT [14]. Despite this, their intracellular networks are far from being static, and can quickly reorganize in response to a variety of extra- or intracellular stimuli. The molecular mechanisms at the basis of IF dynamics appear to depend on the kind of IF, the type of cell, and the specific intracellular location of filaments [8]. Lamin, vimentin and neurofilament polymerization, for instance, occurs at a slower rate than that of keratin [15], with the majority of nascent filaments moving in anterograde direction toward the cell surface. Keratin assembly, on the contrary, occurs principally at the cell periphery, and newly formed filaments are continually shifted toward the cell center [16]. The presence of intact MF and MT is required to support these movements, as transport of IF precursors relies on motor proteins associated with MT (kinesins and dyneins), and MF (myosins) [17,18,19,20,21,22]. All three cytoskeletal systems are thus largely interconnected, both functionally and physically. Vimentin IF and MT are tightly linked in human fibroblasts [23], with the pharmacological fragmentation of MT leading to the collapse of vimentin networks [17,23,24,25]. Bundling of vimentin IF by antibody injection, however, did not alter MT structure, indicating that MT-IF interactions are functionally unidirectional [26,27,28].
Contrary to MF and MT, IF lack polarity and are not exploited as rails for intracellular transport. IF do, however, participate in a variety of trafficking events, including sorting of endo-lysosomes, mitochondria, and Golgi stacks [29], targeting of proteins to specific locations [29], and transmission of signals from the periphery to the nucleus for gene expression control [30]. IF are also crucial for proper shaping [31], positioning [32] and anchoring [33] of the nucleus, and to reduce the impact of mechanical and other types of stress on key cellular activities [13].

1.2. Human Herpesviruses and Their Tropisms

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), varicella zoster virus (VZV), human cytomegalovirus (CMV), human herpesvirus-6 and -7 (HHV-6 and HHV-7), Epstein-Barr virus (EBV) and Kaposi’s sarcoma associated herpesvirus (KSHV) comprise the eight currently known human members of the Herpesviridae family (Table 2). All share a similar virion structure, consisting of a linear, double-stranded DNA molecule densely packaged into an icosahedral capsid, with a diameter of 115–130 nm. The capsid is surrounded by an amorphous protein layer, called the tegument, consisting of more than 30 proteins of viral and cellular origin, and by a lipid envelope containing approximately 10–12 viral glycoproteins plus a few cellular polypeptides [34]. Infectious virions are spherical, and measure approximately 200 nm in diameter.
All herpesviruses are species-specific, but the range of cell types and tissues they can infect within each species varies widely. In vitro, HSV-1 and HSV-2 can enter most primary and established cells lines, while in vivo their tropism is highly restricted to the epithelial cells of the oropharyngeal, respiratory and genital mucosae and to the innervating sensory neurons, where they establish latency [35,36]. In contrast to HSV, the range of cells permissive to VZV infection in vitro is extremely limited, whereas in vivo this virus can infect not only epithelial cells and neurons, but also monocytes, dendritic cells, and T and B lymphocytes [37].
Almost all cell types, with the notable exception of lymphocytes and polimorphonuclear leukocytes, are permissive to CMV infection in vivo [38]. Consequently, virtually all organs have been found to harbor replicating virus in acutely infected individuals [39,40]. Among permissive cell types, fibroblasts, epithelial, endothelial, smooth muscle and dendritic cells are particularly relevant to the development of disease, acting as sites of virus amplification, spread and immune evasion [38,39,41,42,43,44,45], while CD34+ hematopoietic progenitors and monocytes are major reservoirs of latent virus [38,46]. In vitro HHV-6 replicates most efficiently in activated CD4+ lymphocytes, but can infect additional cell types including NK, liver, epithelial, endothelial and dendritic cells, fibroblasts, fetal astrocytes, and microglia [47]. In vivo, this virus is frequently detected in CD4+ T cells and endothelial cells, brain and liver tissue, tonsils and salivary glands and, in latent form, in monocytes [47,48,49].
Although B lymphocytes and epithelial cells are the main targets of EBV infection, numerous other cell types can be infected in vivo, including T lymphocytes, dendritic cells, NK and smooth muscle cells. KSHV’s tropism appears to be broader than that of EBV, both in vitro and in vivo, with B cells, endothelial cells, epithelial cells, keratinocytes and fibroblasts all capable of supporting production of viral progeny [50]. Both viruses establish lifelong latency in resting memory B cells [51].
Owing to their broad tissue tropism, herpesviruses are bound to encounter virtually all types of IF during infection in vivo. Despite this, our current knowledge of these interactions is still largely limited to just a few IF proteins.

2. Intermediate Filaments in Herpesvirus Entry

Herpesviruses replicate their genomes in the nucleus. To start productive infection, therefore, penetrated virions must be actively transported from the cell periphery to the nuclear compartment. This is accomplished in essentially two ways, depending on the virus mode of entry [52]. If penetration occurs by fusion of the viral envelope with the plasmalemma, “naked” virions, i.e., capsids and tightly associated tegument proteins, are transported toward the nuclear envelope along cellular MT [53,54,55]. If, by contrast, viral entry occurs by endocytosis or macropinocytosis, the initial movement of virions toward the cell center takes place within cellular vesicles. Upon fusion of the viral envelope with vesicular membranes, capsids are then released into the cytosol, and reach the perinuclear space by associating, once again, with MT [36,51,52]. The long journey virions endure to enter host cells and reach the nucleus provides IF with numerous opportunities to support or hinder infection initiation (Figure 1).

2.1. Virion Binding at the Cell Surface

Natural transmission of herpesviruses occurs by contact between virions present in the bodily fluids of infected individuals and the oral or ano-genital mucosae of a new host. The epithelial cells and keratinocytes lining these openings express different types of keratins, while fibroblasts and endothelial cells in the underlying connective tissues contain vimentin. Both proteins can be exposed at the cell surface, where they may participate in cell-pathogen interactions.
Keratins are deposited outside of the cell in specific areas of the mouth such as the hard palate, the gingiva, the tongue and the outer lip [56]. Their presence at these sites usually provides an effective barrier against pathogen invasion, although several bacteria were shown to use surface keratins as host-binding anchors [57,58,59,60,61]. Although the actual presence of non-keratin types of IF at the cell surface is still under debate and a matter of controversy, extracellular exposure of vimentin was reported to favor attachment and internalization of viruses such as the porcine reproductive and respiratory syndrome virus [62], human immunodeficiency virus-1 [63], and Theiler’s murine encephalomyelitis virus [64]. As the entry process of most herpesviruses, except EBV, begins with virion attachment to the ubiquitous heparan sulfate proteoglycans [65], surface keratins are unlikely to act as primary sites of virion binding to the cell surface, although a role for these proteins in strengthening these initial virus-host contacts remains possible (Figure 1A). Primary HSV infection of the oral cavity generally occurs within non-keratinized tissues [66], and in an organotypic culture system mimicking stratified human epithelia, successful initiation of HSV-1 infection required virions to slip through microabrasions in the keratinized suprabasal layers of the epithelium [67]. At least for HSV, thus, keratins appear to hinder, rather than promote, virion entry. Whether surface vimentin plays any role in supporting initiation of herpesvirus infection, by contrast, remains to be determined.

2.2. Virion Penetration

All herpesviruses enter host cells by fusion of the viral envelope with cell surface or vesicular membranes, depending on the complement of proteins present on the virion and on the cell type [52]. CMV entry into epithelial and endothelial cells, for instance, occurs by macropinocytosis followed by capsids release in a low-pH-dependent [68,69] or independent [70,71] way, and requires the presence of the gH/gL/UL128/UL130/UL131A complex on the viral envelope [43,72,73]. CMV strains lacking this complex have a more limited tropism, and enter cells by fusion at the plasma membrane [38]. Engagement of cellular vesicles is also required for entry of HSV into epithelial cells such as keratinocytes and HeLa cells, and of EBV into B cells, while penetration of HSV into fibroblasts, neurons and African green monkey kidney epithelial cells, and of EBV into primary human foreskin epithelial cells occurs by fusion at the cell surface [74,75,76,77].
All herpesviruses enter host cells by fusion of the viral envelope with cell surface or vesicular membranes. Irrespective of the mechanism used, herpesvirus entry usually leads to MF remodeling, accompanied or not by filament disassembly, while the structural integrity of MT is generally maintained to support capsid transport toward the nucleus [78,79,80,81,82,83,84,85,86,87]. Currently available data also point at a remarkable conservation of IF networks [83,84,85,88,89], suggesting that the integrity of this system may be required for viral entry. In a recent work, we tested this hypothesis using human fibroblasts and two different CMV strains, one entering cells by fusion at the plasma membrane (AD169) [90] and one expected to enter by fusion with both surface and vesicular membranes (TB40/E) [83]. Penetration of both types of virions was severely impaired in cells where the vimentin cytoskeleton had been disrupted with acrylamide, a neurotoxin causing IF collapse in perinuclear aggregates [25]. Onset of infection was also delayed (AD169), and both delayed and reduced (TB40/E), by vimentin bundling in fibroblasts from patients with giant axonal neuropathy. Finally, the complete absence of this protein in vimentin−/− mouse embryo fibroblasts deferred AD169 particle translocation across the cytosol, and completely blocked progression of TB40/E virions [83]. These results show that the presence of an intact vimentin network is required for CMV infection onset, and hint at a differential role for these IF in supporting virion progress toward the nucleus. Virion entry by fusion at the cell surface, indeed, appeared to be less dramatically affected by the absence of vimentin than entry by macropinocytosis, suggesting that vimentin’s role in managing intracellular vesicles’ movement may be more relevant to CMV infection than its scaffolding functions at the cell periphery.
Whether other types of IF are required for viral entry in clinically-relevant cells like epithelial cells and neurons, and whether the presence of intact vimentin networks is also necessary for infection with other herpesviruses besides CMV remains to be determined. Also to be explored is the precise role played by IF during herpesvirus entry, a task complicated by the fact that the exact function of numerous IF proteins has not yet been established. Based on current knowledge, however, the following possibilities may be envisaged: (i) being tightly connected with MT, some IF proteins might facilitate binding of penetrated capsids to MT motor proteins at the cell periphery (Figure 1B); (ii) vimentin interacts with integrins α2β1, α6β4 and αVβ3 at the cell surface, and mediates recycling of integrin-containing endocytic vesicles [91,92]. These IF could thus support entry of herpesviruses that use integrins as receptors, such as CMV [93,94,95], KSHV [96,97], and EBV [98], by enhancing the internalization of vesicles containing virion-integrin complexes (Figure 1C); (iii) vimentin also accompanies endocytic vesicles in their migration toward the nucleus [99] and, together with the glial fibrillary acidic protein (GFAP), promotes the directional mobility of vesicles in astrocytes [100]. These functions could thus be exploited by endocytosed viral particles to traffic from the periphery to the center of the cell (Figure 1D). Vimentin’s role in stimulating clathrin uncoating from endocytic vesicles [101], by contrast, may not have an impact on infection onset, as herpesvirus virions are considered to be too large to fit into clathrin-coated endosomes, with the notable exception of KSHV [87,102]; (iv) finally, vimentin, peripherin and α-internexin also bind to AP-3 [103], an adaptor complex that regulates trafficking of vesicles in the endo-lysosomal compartment [104], maintains endo-lysosomal stores of cellular ionic zinc in fibroblasts [105], and controls the intracellular localization of the chloride channel ClC-3 [106], thus potentially contributing to influence lysosomal pH [107,108]. In the absence of vimentin, lysosomes are small, do not properly acidify, and redistribute from their usual disperse cytoplasmic location to a juxtanuclear region [101,103]. Thus, at least in those instances where release of internalized capsids from cellular vesicles is pH-dependent [68,69,74,102,109,110], the presence of vimentin, peripherin or α-internexin may be required to induce the rapid acidification of endo-lysosomes via AP-3 (Figure 1E). Both vimentin and keratins, however, also appear to have a role in stimulating the formation of autophagosomes, as disruption of hepatic keratin networks completely inhibited autophagy [111], while vimentin−/− cells were shown to contain lower number of autophagocytic vesicles than wild-type cells [103]. This specific IF function may thus favor the host, rather than the virus, by fostering the active degradation of penetrated particles. Herpesviruses have indeed evolved a number of strategies to manipulate this cellular defense mechanism, although none have yet been reported to affect IF’s participation in this process [112].

2.3. Viral Genome Deposition into the Nucleus

Dynein-bound capsids traveling along MT [113] are thought to reach the MT-organizing center (MTOC), where most MT plus ends are anchored [114]. This organelle is usually, but not always, located in proximity of the nucleus, at distances spanning from ~1.5 μm in fibroblasts [115] to 5–10 μm in neurons [116]. Exactly how capsids reach the nuclear envelope across this gap, corresponding to about 10- to 80-fold their average size, remains unclear. Although most capsids are initially located close to the MTOC, their distribution becomes more evenly dispersed around the nucleus at later times [117]. The precise mechanisms mediating this spread are also currently unknown.
Electron microscopy imaging of HSV-1 and of murine gammaherpesvirus 68 entry into mammalian cells revealed that, once within 40 nm from the nuclear pore complex (NPC), capsids attach to the filaments radiating from the pore’s outer rim [117,118]. This binding step is followed by the translocation of the viral genome from the capsid into the nucleus through the capsid portal and the NPC, in a process that requires energy and the presence of cellular proteins other than those comprising the nuclear pore, and whose identity is currently unknown [119,120,121].
Cytoplasmic IF form cage-like webs around the nucleus, and can tightly associate with the nuclear envelope and with nuclear IF through a series of mediator proteins, including the recently discovered SUN (Sad1 and UNC-84) and KASH (Klarsicht, Anc-1 and Syne/Nesprin Homology) family members [122,123,124,125,126,127,128]. Thus, nuclear lamins bind to SUN protein dimers located in the inner nuclear membrane (INM). These, in turn, interact with KASH domain-containing proteins residing in the outer nuclear membrane (ONM). One of these proteins, nesprin-3, then completes the link between the nucleus and the IF cytoskeleton by interacting with plectin, an IF-binding protein [129,130]. At least in the case of vimentin, this tight grip of IF on the nuclear envelope was shown to be essential for maintenance of a rounded nuclear shape [31], for anchoring of the nucleus within the cell [131], for force transfer from the periphery toward the cell center [132], and to prevent nuclear spinning [33]. By forming a crate of filaments surrounding the nuclear envelope, IF are likely to dock to the nuclear membrane at multiple locations. Thus, IF could potentially support not only the transfer of capsids from the MTOC to the nucleus, but also their spread along the nuclear envelope, in order to reach NPCs located at greater distances from the centrosome (Figure 1F). Evidence in favor of a role for vimentin in fostering uptake of HIV-1 preintegration complexes into the nucleus has indeed been provided [63].

3. Intermediate Filaments in Herpesvirus Replication

Following genome deposition into the nucleus, transcription of the viral immediate-early (IE) genes must occur to start productive viral replication, while their silencing is required to establish latency.
Several lamina proteins were recently shown to participate in gene expression control by recruiting transcription factors and chromatin modifying enzymes to the nuclear periphery, thus leading to the formation of a transcriptionally repressive environment that is interrupted only in proximity of the nuclear pores [133]. For instance, while lamin A itself can inhibit gene expression when artificially tethered to promoters, [134], the lamina-associated protein 2β mediates transcriptional silencing by stimulating histone H4 deacetylation after binding to histone deacetylase 3 [135]. The lamin B receptor protein (LBR), by contrast, supports heterochromatin anchoring to the nuclear envelope by interacting with the heterochromatin protein 1 and with deacetylated histones H3/H4 [136].
Regularly spaced nucleosomes displaying the typical markers of heterochromatin are also usually associated with latent viral genomes maintained in episomal form within the nucleus of specific cells [137]. This transcriptionally silent status is reversed during reactivation bouts, possibly via reductions in the number of genome-associated histones, or via histone acetylation. Although a few viral and cellular proteins with roles in controlling these events have already been identified, a number of questions regarding the mechanisms and players involved in viral genome silencing during latency remain open [137]. Because of the prominent participation of the nuclear lamina in mediating transcriptional repression, nuclear IF are highly likely to be involved in viral latency establishment and/or maintenance, although this possibility has not yet been explored. By contrast, a role for lamin A in supporting the viral lytic replication cycle has been demonstrated [138]. In the absence of this lamin, nascent replication compartments were no longer retained within transcriptionally active areas of the nucleus, leading to increased heterochromatinization of the viral genome, strong inhibition of IE protein expression, and markedly reduced viral yields [138].
Other types of IF besides the lamins could also, potentially, be involved in herpesvirus replication events, on account of their involvement in intracellular signaling cascades [29]. Keratin mutation, GFAP overexpression and desmin downregulation were indeed shown to lead to changes in cellular gene transcription [29,139,140,141]. Theoretically, thus, these IF proteins could affect viral gene expression during both productive and latent life cycles (Figure 1G).
Progression of herpesvirus infection is also associated with dramatic changes in transcription levels of numerous cellular genes, including those encoding IF proteins (Table 3). Although the relevance of these changes for viral replication has not been fully established, they are likely to contribute to the pathological consequences of infection. The impact of VZV infection on IF gene expression, for instance, appears to be highly cell type-dependent, with the majority of changes observed in infected human skin implants in SCID mice (Table 3) [142]. In this tissue, transcription of numerous keratin genes was down-regulated, providing a possible molecular basis for the development of the typical skin blisters observed in patients with chickenpox. Moreover, the concomitant up-regulation of vimentin expression may indicate the onset of epithelial-to-mesenchymal transitions. In contrast, CMV infection of fibroblasts appeared to induce the appearance of an opposite phenotype, with reductions in vimentin, syncoilin and keratin 19 expression, and induction of keratin 5, 13, 18, 85 and 86 synthesis [143]. CMV infection in human neural progenitor cells also leads to the marked down-regulation of GFAP expression, and to the skewing of these cells’ differentiation toward a nonneuronal lineage. Both events are likely to lead to the severe nervous system malformations observed in newborns with cytomegalic inclusion disease [144]. Finally, transcription of different keratin genes is also altered in tissues infected with EBV or KSHV [145,146,147], while expression of EBV LMP or EBNA4 proteins stimulated expression of vimentin [148,149,150], but the significance of these changes for viral pathogenesis is still unclear.

4. Intermediate Filaments in Herpesvirus Egress

After being filled with newly replicated viral genomes, nucleocapsids leave the nucleus by sequentially budding through the INM and ONM in the so-called envelopment-deenvelopment-reenvelopment process, followed by the acquisition of tegument proteins and envelope membranes from the trans-Golgi network and the ER in the cytoplasm. Mature virions are then incorporated into exocytic vesicles for release at the cell surface [153,154,155]. Once again, this itinerary provides herpesviruses with numerous opportunities to interact with a variety of IF proteins.

4.1. Nucleocapsid Egress from the Nucleus

Because of their size (115–130 nm), herpesvirus nucleocapsids cannot exit the nucleus through the NPC, whose functional internal diameter measures 38 nm in size. All other passageways to the cytoplasm necessarily entail crossing of the nuclear envelope, whose INM, however, is supported and protected by a dense IF network composed of A- and B-type lamins, and of their partners [156]. As destabilization of the nuclear lamina is required for capsids to reach the INM, all herpesviruses have been reported to induce changes in the structure and/or distribution of lamina components at late times post-infection. Although the exact mechanisms mediating these rearrangements are not completely understood, they are thought to depend, at least in part, on lamin phosphorylation events, similar to those leading to the dissolution of the nuclear envelope during mitosis [154].
At late times post-infection with HSV-1, the usually uniform distribution of lamin A/C and B at the nuclear rim becomes irregular and discontinuous. While a proportion of the lamin B and LBR proteins is relocated to a perinuclear cytoplasmic region, possibly corresponding to the ER [157,158], changes occurring to the lamin A/C proteins appear to be more conformational than positional [159]. Lamin A/C and B amounts were also reduced in infected COS-1 cells [157], while no change in lamin A/C and lamin-associated protein 2 levels were detected in infected Vero cells [160]. This suggests that degradation of lamina components is cell type-specific, and is not necessarily required for its disruption. Both lamin B and the lamina-associated protein emerin are phosphorylated during infection [158,161], leading to the loss of connections between emerin and the nuclear membrane [162]. Lamin A/C is also phosphorylated on multiple sites by the viral kinases US3 and UL13, at least in vitro [163,164]. Whether these phosphorylation events are sufficient to induce fragmentation of the lamina to the extent required for virions to access the INM is unknown. Expression of HSV-2 UL13 alone, however, was shown to almost completely recapitulate the changes in lamin A/C and B distribution observed in infected cells [164].
According to the current model, the HSV nuclear egress complex (NEC) consists of the following components [158,159,160,161,162,163,164,165,166,167,168,169] (Figure 2, left): a UL34-UL31 heterodimer, anchored to the INM via the transmembrane domain of UL34; the viral kinase UL13, which can phosphorylate US3, lamin A/C and lamin B, and regulates UL31 and UL34 recruitment to the INM; the viral kinase US3, which phosphorylates UL34 and lamin A/C, but is not necessary for lamina disruption, and may instead function as a negative regulator of the process; PKCα and PKCδ, which are recruited to the INM by the UL34-UL31 complex and are responsible for at least part of the observed phosphorylation of lamin A/C and B, and other, as yet unidentified, cellular kinases mediating emerin phosphorylation.
Quite interestingly, although lamins constitute a formidable barrier to nucleocapsid egress from the nucleus, and could thus be considered negative regulators of infection, HSV-1 titers are decreased (instead of increased) by at least 10-fold in LmnB1−/− murine fibroblasts lacking expression of lamin B1 [170]. This suggests that lamin B is required for efficient viral replication, possibly because of its function in gene transcription and DNA replication [171,172]. Finally, although rearrangement of the nuclear lamina is required for efficient replication, it is possible for nucleocapsids to leave the nucleus in the absence of these changes, as mutant viruses lacking expression of UL31 and UL34 can still replicate to some extent in non-complementing cells [166]. Intriguingly, the nuclei of cells infected with bovine herpesvirus 1 were shown to contain large gaps through which nucleocapsids could reach the cytoplasm without budding into nuclear membranes [173]. Although the existence of these gaps is still a matter of debate, their generation may involve different kinds of interaction with the lamina than those mediating its dissolution, potentially requiring the activity of an alternative set of viral proteins.
CMV infection of human fibroblasts also profoundly modifies the structure of the lamina, inducing the appearance of deep INM invaginations that may favor capsid egress by acting as channels for the direct transport of virions towards the ONM [174,175,176,177,178]. The requirement for the presence of two viral proteins, M50 and M53, to achieve dissolution of the nuclear lamina was first demonstrated for murine CMV [179]. Their human CMV homologs, UL50 and UL53, were subsequently shown to be part of the CMV NEC (Figure 2, center), together with the viral kinase UL97, and the cellular proteins p32, LBR and PKC [180]. A new viral protein we just identified and named RASCAL also appears to localize to the NEC, likely through interactions with UL50 [82], while recruitment of the cellular peptidyl-prolyl cis/trans isomerase Pin1 to the nuclear rim was recently described to occur by binding to phosphorylated lamin A/C [181].
How, exactly, the nuclear lamina is disassembled during CMV infection is not completely understood. The complete disappearance of lamin A/C at late times post-infection has been described in some [182,183], but not other [82,184,185] reports. Whether proteolytic degradation of this lamin occurs and, if so, how much it contributes to the whole disassembly process is therefore still uncertain. Also unclear is whether expression of UL50 and UL53 alone can support these changes as described in COS7 cells [184], or whether their main function is to recruit other NEC components including the kinases PKC and UL97, whose activity, by contrast, is absolutely required for lamina disassembly [179,180,181,182,185,186,187]. Because of its role in lamin A/C phosphorylation, UL97 has been proposed to act as a viral analog of the cellular cyclin-dependent kinase 1 (CDK1) [188], which supports dissolution of the nuclear lamina during mitosis [189]. Interestingly, the appearance of pathological mitoses, characterized by the presence of multiple spindle poles and by the complete dissolution of the nuclear envelope, was observed to occur at late times post-infection with different strains of CMV, but in substantial amounts during infection with the fibroblast-adapted strain AD169 [190,191]. Pseudomitoses generation required the presence of CDK1, but the activity of this kinase was dispensable for the production and release of new viral particles [191]. By contrast, the simultaneous inhibition of multiple cyclin-dependent kinases, coupled or not to the inhibition of UL97, substantially reduced viral yields [191]. These results suggest that CMV may use a number of different cellular kinases, in addition to PKC and UL97, to support dissolution of the nuclear lamina during egress. Additionally, induction of pseudomitoses per se may represent an alternative method for CMV virions to leave the nucleus, since their presence in more than one quarter of infected cells did not have any negative effect on viral yields.
Finally, not much is known about the impact of EBV or KSHV infection on the nuclear lamina. In striking contrast to HSV and CMV infection, which cause a dissociation of the INM and ONM, EBV infection induces duplications of the nuclear membrane [192]. These were generated by the activity of the viral protein BFRF1, which localizes at the nuclear rim, interacts with lamin B and recruits a second viral protein, BFLF2, a putative modulator of BFRF1 activity [193,194,195]. Similar to the alpha and beta herpesviruses, however, EBV also appears to encode a nuclear rim-localized kinase, BGLF4, which can induce lamina disassembly by lamin A/C phosphorylation [154,196] (Figure 2, right).

4.2. Subviral Particle Trafficking from the Nucleus to the Cell Surface

After leaving the ONM, nucleocapsids must cross the cytoplasm to reach the cell surface. During infection with a variety of viruses, this step is associated with IF disassembly, possibly to enhance the speed of capsid movement by reducing the viscosity of the cytoplasm. Infection of epithelial cells with HSV-1 was indeed shown to cause partial proteolysis of keratins [197], while keratin 17 phosphorylation by HSV-2 US3 kinase was associated with reductions in these IF’s density [198]. However, considering the complexity of herpesvirus maturation in the cytoplasm, a role for IF in supporting, instead of hindering, herpesvirus egress is far more likely.
The interactions between vimentin, keratin and neurofilament IF and the Golgi apparatus [29], for instance, may be important for transfer of intracellular membranes to virions during their envelopment. In addition, desmin, keratins and neurofilaments are essential to maintain the correct morphology, distribution and function of mitochondria. In heart and skeletal muscles of desmin-null mice, mitochondria are misshapen and mislocalized, leading to a decrease in energy production and to the induction of apoptosis [199,200], while in neurons from patients with Charcot-Marie-Tooth disease caused by mutations in the neurofilament light subunit gene NF-L, mitochondria cluster close to the cell soma, leading to defects in axonal transport [201]. Through their interaction with mitochondria, thus, IF may support herpesvirus infection by securing an uninterrupted flow of energy, required to fuel viral genome synthesis and capsid transport. Also, IF may cooperate with viral anti-apoptotic proteins to prevent cell death. Finally, IF have a prominent role in targeting a variety of proteins to the plasma membrane [29], and in anchoring cells to each other as well as to the substratum by attaching to desmosomes and hemidesmosomes, respectively [202]. These functions could thus be exploited by maturing virions to promote the delivery of specific proteins to the sites of fusion between exocytic vesicles and the plasmalemma, and to target virion egress to the sites of cell-to-cell contact for lateral transmission within tissues. The NP protein of the lymphocytic choriomeningitis virus was indeed shown to promote intercellular spread of mature virions by binding to keratin 1 and stabilizing its filaments, leading to the establishment of stronger cell-to-cell contacts that favored viral transmission [203]. A similar role for keratins and other types of IF can be easily envisaged during herpesvirus egress, particularly so in the case of HSV and VZV, whose transmission and pathological manifestations involve keratinized organs such as the skin.

5. Concluding Remarks

In summary, IF are highly dynamic structures whose role in cellular physiology is just starting to be unraveled. The analysis of their functions during herpesvirus infections is certain to provide exciting new insights into how key steps of the viral cycle are completed, and is likely to lead to potentially new avenues in the treatment of herpesvirus infections.

References and Notes

  1. Liem, R.K.; Messing, A. Dysfunctions of neuronal and glial intermediate filaments in disease. J. Clin. Invest. 2009, 119, 1814–1824. [Google Scholar] [CrossRef] [PubMed]
  2. Eriksson, J.E.; Dechat, T.; Grin, B.; Helfand, B.; Mendez, M.; Pallari, H.M.; Goldman, R.D. Introducing intermediate filaments: From discovery to disease. J. Clin. Invest. 2009, 119, 1763–1771. [Google Scholar] [CrossRef] [PubMed]
  3. Herrmann, H.; Strelkov, S.V.; Burkhard, P.; Aebi, U. Intermediate filaments: Primary determinants of cell architecture and plasticity. J. Clin. Invest. 2009, 119, 1772–1783. [Google Scholar] [CrossRef] [PubMed]
  4. Omary, M.B. "IF-pathies": A broad spectrum of intermediate filament-associated diseases. J. Clin. Invest. 2009, 119, 1756–1762. [Google Scholar] [CrossRef] [PubMed]
  5. Szeverenyi, I.; Cassidy, A.J.; Chung, C.W.; Lee, B.T.; Common, J.E.; Ogg, S.C.; Chen, H.; Sim, S.Y.; Goh, W.L.; Ng, K.W.; et al. The Human Intermediate Filament Database: Comprehensive information on a gene family involved in many human diseases. Hum. Mutat. 2008, 29, 351–360. [Google Scholar] [CrossRef] [PubMed]
  6. Herrmann, H.; Bar, H.; Kreplak, L.; Strelkov, S.V.; Aebi, U. Intermediate filaments: From cell architecture to nanomechanics. Nat. Rev. Mol. Cell Biol. 2007, 8, 562–573. [Google Scholar] [CrossRef]
  7. Kim, S.; Coulombe, P.A. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007, 21, 1581–1597. [Google Scholar] [CrossRef]
  8. Godsel, L.M.; Hobbs, R.P.; Green, K.J. Intermediate filament assembly: Dynamics to disease. Trends Cell Biol. 2008, 18, 28–37. [Google Scholar] [CrossRef]
  9. Amann, K.J.; Pollard, T.D. Cellular regulation of actin network assembly. Curr. Biol. 2000, 10, R728–R730. [Google Scholar] [CrossRef]
  10. Margolis, R.L.; Wilson, L. Microtubule treadmills—Possible molecular machinery. Nature 1981, 293, 705–711. [Google Scholar] [CrossRef]
  11. Strelkov, S.V.; Herrmann, H.; Aebi, U. Molecular architecture of intermediate filaments. Bioessays 2003, 25, 243–251. [Google Scholar] [CrossRef]
  12. Nguyen, M.D.; Shu, T.; Sanada, K.; Lariviere, R.C.; Tseng, H.C.; Park, S.K.; Julien, J.P.; Tsai, L.H. A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons. Nat. Cell Biol. 2004, 6, 595–608. [Google Scholar] [CrossRef]
  13. Omary, M.B.; Ku, N.O.; Tao, G.Z.; Toivola, D.M.; Liao, J. "Heads and tails" of intermediate filament phosphorylation: Multiple sites and functional insights. Trends Biochem. Sci. 2006, 31, 383–394. [Google Scholar] [CrossRef]
  14. Wagner, O.I.; Rammensee, S.; Korde, N.; Wen, Q.; Leterrier, J.F.; Janmey, P.A. Softness, strength and self-repair in intermediate filament networks. Exp. Cell Res. 2007, 313, 2228–2235. [Google Scholar] [CrossRef]
  15. Herrmann, H.; Aebi, U. Intermediate filaments: Molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu. Rev. Biochem. 2004, 73, 749–789. [Google Scholar] [CrossRef]
  16. Kolsch, A.; Windoffer, R.; Wurflinger, T.; Aach, T.; Leube, R.E. The keratin-filament cycle of assembly and disassembly. J. Cell Sci. 2010, 123, 2266–2272. [Google Scholar] [CrossRef]
  17. Prahlad, V.; Yoon, M.; Moir, R.D.; Vale, R.D.; Goldman, R.D. Rapid movements of vimentin on microtubule tracks: Kinesin-dependent assembly of intermediate filament networks. J. Cell Biol. 1998, 143, 159–170. [Google Scholar] [CrossRef]
  18. Martys, J.L.; Ho, C.L.; Liem, R.K.; Gundersen, G.G. Intermediate filaments in motion: Observations of intermediate filaments in cells using green fluorescent protein-vimentin. Mol. Biol. Cell 1999, 10, 1289–1295. [Google Scholar] [CrossRef]
  19. Yabe, J.T.; Pimenta, A.; Shea, T.B. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J. Cell Sci. 1999, 112, 3799–3814. [Google Scholar] [CrossRef]
  20. Motil, J.; Chan, W.K.; Dubey, M.; Chaudhury, P.; Pimenta, A.; Chylinski, T.M.; Ortiz, D.T.; Shea, T.B. Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: Regulation by multiple phosphorylation events. Cell Motil. Cytoskeleton 2006, 63, 266–286. [Google Scholar] [CrossRef]
  21. Shah, J.V.; Flanagan, L.A.; Janmey, P.A.; Leterrier, J.F. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol. Biol. Cell 2000, 11, 3495–3508. [Google Scholar] [CrossRef] [PubMed]
  22. Helfand, B.T.; Loomis, P.; Yoon, M.; Goldman, R.D. Rapid transport of neural intermediate filament protein. J. Cell Sci. 2003, 116, 2345–2359. [Google Scholar] [CrossRef] [PubMed]
  23. Goldman, R.D. The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine. J. Cell Biol. 1971, 51, 752–762. [Google Scholar] [CrossRef] [PubMed]
  24. Franke, W.W.; Schmid, E.; Osborn, M.; Weber, K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc. Natl. Acad. Sci. U. S. A. 1978, 75, 5034–5038. [Google Scholar] [CrossRef]
  25. Aggeler, J.; Seely, K. Cytoskeletal dynamics in rabbit synovial fibroblasts: I. Effects of acrylamide on intermediate filaments and microfilaments. Cell Motil. Cytoskeleton 1990, 16, 110–120. [Google Scholar] [CrossRef]
  26. Klymkowsky, M.W. Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature 1981, 291, 249–251. [Google Scholar] [CrossRef]
  27. Lin, J.J.; Feramisco, J.R. Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. Cell 1981, 24, 185–193. [Google Scholar] [CrossRef]
  28. Gawlitta, W.; Osborn, M.; Weber, K. Coiling of intermediate filaments induced by microinjection of a vimentin-specific antibody does not interfere with locomotion and mitosis. Eur. J. Cell Biol. 1981, 26, 83–90. [Google Scholar]
  29. Toivola, D.M.; Tao, G.Z.; Habtezion, A.; Liao, J.; Omary, M.B. Cellular integrity plus: Organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 2005, 15, 608–617. [Google Scholar] [CrossRef]
  30. Pallari, H.M.; Eriksson, J.E. Intermediate filaments as signaling platforms. Sci. STKE 2006, 2006, pe53. [Google Scholar] [CrossRef]
  31. Sarria, A.J.; Lieber, J.G.; Nordeen, S.K.; Evans, R.M. The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells. J. Cell Sci. 1994, 107, 1593–1607. [Google Scholar] [CrossRef]
  32. Shah, S.B.; Davis, J.; Weisleder, N.; Kostavassili, I.; McCulloch, A.D.; Ralston, E.; Capetanaki, Y.; Lieber, R.L. Structural and functional roles of desmin in mouse skeletal muscle during passive deformation. Biophys. J. 2004, 86, 2993–3008. [Google Scholar] [CrossRef]
  33. Gerashchenko, M.V.; Chernoivanenko, I.S.; Moldaver, M.V.; Minin, A.A. Dynein is a motor for nuclear rotation while vimentin IFs is a "brake". Cell Biol. Int. 2009, 33, 1057–1064. [Google Scholar] [CrossRef]
  34. Liu, F.; Hong Zhou, Z. Comparative virion structures of human herpesviruses. In Human Herpesviruses: Biology, Therapy and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007. [Google Scholar]
  35. Mori, I.; Nishiyama, Y. Herpes simplex virus and varicella-zoster virus: Why do these human alphaherpesviruses behave so differently from one another? Rev. Med. Virol. 2005, 15, 393–406. [Google Scholar] [CrossRef]
  36. Campadelli-Fiume, G.; Menotti, L. Entry of alphaherpesviruses into the cell. In Human Herpesviruses: Biology, Therapy and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007. [Google Scholar]
  37. Arvin, A.M.; Moffat, J.F.; Sommer, M.; Oliver, S.; Che, X.; Vleck, S.; Zerboni, L.; Ku, C.C. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Curr. Top. Microbiol. Immunol. 2010, 342, 189–209. [Google Scholar]
  38. Sinzger, C.; Digel, M.; Jahn, G. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 2008, 325, 63–83. [Google Scholar]
  39. Sinzger, C.; Grefte, A.; Plachter, B.; Gouw, A.S.; The, T.H.; Jahn, G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 1995, 76, 741–750. [Google Scholar] [CrossRef]
  40. Bissinger, A.L.; Sinzger, C.; Kaiserling, E.; Jahn, G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J. Med. Virol. 2002, 67, 200–206. [Google Scholar] [CrossRef]
  41. Rolle, A.; Olweus, J. Dendritic cells in cytomegalovirus infection: Viral evasion and host countermeasures. Apmis 2009, 117, 413–426. [Google Scholar] [CrossRef]
  42. Sinclair, J. Manipulation of dendritic cell functions by human cytomegalovirus. Expert Rev. Mol. Med. 2008, 10, e35. [Google Scholar] [CrossRef]
  43. Hahn, G.; Revello, M.G.; Patrone, M.; Percivalle, E.; Campanini, G.; Sarasini, A.; Wagner, M.; Gallina, A.; Milanesi, G.; Koszinowski, U.; et al. Human cytomegalovirus UL131–128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 2004, 78, 10023–10033. [Google Scholar] [CrossRef] [PubMed]
  44. Adler, B.; Sinzger, C. Endothelial cells in human cytomegalovirus infection: One host cell out of many or a crucial target for virus spread? Thromb. Haemost. 2009, 102, 1057–1063. [Google Scholar] [PubMed]
  45. Emery, V.C.; Cope, A.V.; Bowen, E.F.; Gor, D.; Griffiths, P.D. The dynamics of human cytomegalovirus replication in vivo. J. Exp. Med. 1999, 190, 177–182. [Google Scholar] [CrossRef] [PubMed]
  46. Sinclair, J. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J. Clin. Virol. 2008, 41, 180–185. [Google Scholar] [CrossRef] [PubMed]
  47. De Bolle, L.; Naesens, L.; De Clercq, E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 2005, 18, 217–245. [Google Scholar] [CrossRef]
  48. Mori, Y. Recent topics related to human herpesvirus 6 cell tropism. Cell. Microbiol. 2009, 11, 1001–1006. [Google Scholar] [CrossRef]
  49. Wang, F.-Z.; Pellett, P.E. HHV-6A, 6B, and 7: Immunobiology and host response. In Human Herpesviruses: Biology, Therapy and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007. [Google Scholar]
  50. Ganem, D. Kaposi’s sarcoma-associated herpesvirus. In Fields Virology, 5th ed.; Knipe, D., Howley, P., Griffin, D., Lamb, R., Martin, M., Roizman, B., Straus, S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 2875–2888. [Google Scholar]
  51. Chandran, B.; Hutt-Fletcher., L. Gammaherpesviruses entry and early events during infection. In Human Herpesviruses: Biology, Therapy and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007. [Google Scholar]
  52. Mocarski, E.S. Comparative analysis of herpesvirus-common proteins. In Human Herpesviruses: Biology, Therapy and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007. [Google Scholar]
  53. Ogawa-Goto, K.; Tanaka, K.; Gibson, W.; Moriishi, E.; Miura, Y.; Kurata, T.; Irie, S.; Sata, T. Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J. Virol. 2003, 77, 8541–8547. [Google Scholar] [CrossRef]
  54. Mabit, H.; Nakano, M.Y.; Prank, U.; Saam, B.; Dohner, K.; Sodeik, B.; Greber, U.F. Intact microtubules support adenovirus and herpes simplex virus infections. J. Virol. 2002, 76, 9962–9971. [Google Scholar] [CrossRef]
  55. Naranatt, P.P.; Krishnan, H.H.; Smith, M.S.; Chandran, B. Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J. Virol. 2005, 79, 1191–1206. [Google Scholar] [CrossRef]
  56. Adams, D. Keratinization of the oral epithelium. Ann. R. Coll. Surg. Engl. 1976, 58, 351–358. [Google Scholar]
  57. Batchelor, M.; Guignot, J.; Patel, A.; Cummings, N.; Cleary, J.; Knutton, S.; Holden, D.W.; Connerton, I.; Frankel, G. Involvement of the intermediate filament protein cytokeratin-18 in actin pedestal formation during EPEC infection. EMBO Rep. 2004, 5, 104–110. [Google Scholar] [CrossRef]
  58. O'Brien, L.M.; Walsh, E.J.; Massey, R.C.; Peacock, S.J.; Foster, T.J. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: Implications for nasal colonization. Cell. Microbiol. 2002, 4, 759–770. [Google Scholar] [CrossRef]
  59. Samen, U.; Eikmanns, B.J.; Reinscheid, D.J.; Borges, F. The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect. Immun. 2007, 75, 5405–5414. [Google Scholar] [CrossRef]
  60. Carlson, S.A.; Omary, M.B.; Jones, B.D. Identification of cytokeratins as accessory mediators of Salmonella entry into eukaryotic cells. Life Sci. 2002, 70, 1415–1426. [Google Scholar] [CrossRef]
  61. Tamura, G.S.; Nittayajarn, A. Group B streptococci and other gram-positive cocci bind to cytokeratin 8. Infect. Immun. 2000, 68, 2129–2134. [Google Scholar] [CrossRef]
  62. Kim, J.K.; Fahad, A.M.; Shanmukhappa, K.; Kapil, S. Defining the cellular target(s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J. Virol. 2006, 80, 689–696. [Google Scholar] [CrossRef]
  63. Thomas, E.K.; Connelly, R.J.; Pennathur, S.; Dubrovsky, L.; Haffar, O.K.; Bukrinsky, M.I. Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: A possible role of intermediate filaments in the early steps of HIV-1 infection cycle. Viral. Immunol. 1996, 9, 73–87. [Google Scholar] [CrossRef]
  64. Nedellec, P.; Vicart, P.; Laurent-Winter, C.; Martinat, C.; Prevost, M.C.; Brahic, M. Interaction of Theiler's virus with intermediate filaments of infected cells. J. Virol. 1998, 72, 9553–9560. [Google Scholar] [CrossRef]
  65. Spear, P.G.; Longnecker, R. Herpesvirus entry: An update. J. Virol. 2003, 77, 10179–10185. [Google Scholar] [CrossRef]
  66. Spruance, S.L. Pathogenesis of herpes simplex labialis: Excretion of virus in the oral cavity. J. Clin. Microbiol. 1984, 19, 675–679. [Google Scholar] [CrossRef]
  67. Visalli, R.J.; Courtney, R.J.; Meyers, C. Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology 1997, 230, 236–243. [Google Scholar] [CrossRef] [PubMed]
  68. Ryckman, B.J.; Jarvis, M.A.; Drummond, D.D.; Nelson, J.A.; Johnson, D.C. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 2006, 80, 710–722. [Google Scholar] [CrossRef] [PubMed]
  69. Ryckman, B.J.; Rainish, B.L.; Chase, M.C.; Borton, J.A.; Nelson, J.A.; Jarvis, M.A.; Johnson, D.C. Characterization of the human cytomegalovirus gH/gL/UL128–131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 2008, 82, 60–70. [Google Scholar] [CrossRef] [PubMed]
  70. Sinzger, C. Entry route of HCMV into endothelial cells. J. Clin. Virol. 2008, 41, 174–179. [Google Scholar] [CrossRef] [PubMed]
  71. Patrone, M.; Secchi, M.; Bonaparte, E.; Milanesi, G.; Gallina, A. Cytomegalovirus UL131–128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells. J. Virol. 2007, 81, 11479–11488. [Google Scholar] [CrossRef]
  72. Wang, D.; Shenk, T. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 18153–18158. [Google Scholar] [CrossRef]
  73. Wang, D.; Shenk, T. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J. Virol. 2005, 79, 10330–10338. [Google Scholar] [CrossRef]
  74. Nicola, A.V.; McEvoy, A.M.; Straus, S.E. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 2003, 77, 5324–5332. [Google Scholar] [CrossRef]
  75. Nicola, A.V.; Straus, S.E. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J. Virol. 2004, 78, 7508–7517. [Google Scholar] [CrossRef]
  76. Nicola, A.V.; Hou, J.; Major, E.O.; Straus, S.E. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J. Virol. 2005, 79, 7609–7616. [Google Scholar] [CrossRef]
  77. Miller, N.; Hutt-Fletcher, L.M. Epstein-Barr virus enters B cells and epithelial cells by different routes. J. Virol. 1992, 66, 3409–3414. [Google Scholar] [CrossRef]
  78. Roberts, K.L.; Baines, J.D. Actin in Herpesvirus Infection. Viruses 2011, 3, 336–346. [Google Scholar] [CrossRef]
  79. Arcangeletti, M.C.; Pinardi, F.; Medici, M.C.; Pilotti, E.; De Conto, F.; Ferraglia, F.; Landini, M.P.; Chezzi, C.; Dettori, G. Cytoskeleton involvement during human cytomegalovirus replicative cycle in human embryo fibroblasts. New Microbiol. 2000, 23, 241–256. [Google Scholar]
  80. Jones, N.L.; Lewis, J.C.; Kilpatrick, B.A. Cytoskeletal disruption during human cytomegalovirus infection of human lung fibroblasts. Eur. J. Cell Biol. 1986, 41, 304–312. [Google Scholar]
  81. Losse, D.; Lauer, R.; Weder, D.; Radsak, K. Actin distribution and synthesis in human fibroblasts infected by cytomegalovirus. Arch. Virol. 1982, 71, 353–359. [Google Scholar] [CrossRef]
  82. Miller, M.S.; Furlong, W.E.; Pennell, L.; Geadah, M.; Hertel, L. RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection. J. Virol. 2010, 84, 6483–6496. [Google Scholar] [CrossRef]
  83. Miller, M.S.; Hertel, L. Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton. J. Virol. 2009, 83, 7015–7028. [Google Scholar] [CrossRef]
  84. Norrild, B.; Lehto, V.P.; Virtanen, I. Organization of cytoskeleton elements during herpes simplex virus type 1 infection of human fibroblasts: An immunofluorescence study. J. Gen. Virol. 1986, 67, 97–105. [Google Scholar] [CrossRef]
  85. Dienes, H.P.; Hiller, G.; Muller, S.; Falke, D. Microtubules and intermediate filaments of herpes simplex virus infected cells. Arch. Virol. 1987, 94, 15–28. [Google Scholar] [CrossRef]
  86. Lyman, M.G.; Enquist, L.W. Herpesvirus interactions with the host cytoskeleton. J. Virol. 2008, 83, 2058–2066. [Google Scholar] [CrossRef]
  87. Chandran, B. Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J. Virol. 2010, 84, 2188–2199. [Google Scholar] [CrossRef] [PubMed]
  88. Walter, I.; Nowotny, N. Equine herpes virus type 1 (EHV-1) infection induces alterations in the cytoskeleton of vero cells but not apoptosis. Arch. Virol. 1999, 144, 1827–1836. [Google Scholar] [CrossRef] [PubMed]
  89. Kuhn, M.; Desloges, N.; Rahaus, M.; Wolff, M.H. Varicella-zoster virus infection influences expression and organization of actin and alpha-tubulin but does not affect lamin A and vimentin. Intervirology 2005, 48, 312–320. [Google Scholar] [CrossRef] [PubMed]
  90. Compton, T.; Nepomuceno, R.R.; Nowlin, D.M. Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 1992, 191, 387–395. [Google Scholar] [CrossRef] [PubMed]
  91. Ivaska, J.; Pallari, H.M.; Nevo, J.; Eriksson, J.E. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 2007, 313, 2050–2062. [Google Scholar] [CrossRef]
  92. Ivaska, J.; Vuoriluoto, K.; Huovinen, T.; Izawa, I.; Inagaki, M.; Parker, P.J. PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 2005, 24, 3834–3845. [Google Scholar] [CrossRef]
  93. Feire, A.L.; Koss, H.; Compton, T. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 15470–15475. [Google Scholar] [CrossRef]
  94. Wang, X.; Huang, D.Y.; Huong, S.M.; Huang, E.S. Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat. Med. 2005, 11, 515–521. [Google Scholar] [CrossRef]
  95. Isaacson, M.K.; Juckem, L.K.; Compton, T. Virus entry and innate immune activation. Curr. Top. Microbiol. Immunol. 2008, 325, 85–100. [Google Scholar]
  96. Akula, S.M.; Pramod, N.P.; Wang, F.Z.; Chandran, B. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 2002, 108, 407–419. [Google Scholar] [CrossRef]
  97. Veettil, M.V.; Sadagopan, S.; Sharma-Walia, N.; Wang, F.Z.; Raghu, H.; Varga, L.; Chandran, B. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J. Virol. 2008, 82, 12126–12144. [Google Scholar]
  98. Chesnokova, L.S.; Nishimura, S.L.; Hutt-Fletcher, L.M. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 20464–20469. [Google Scholar] [CrossRef]
  99. Herman, B.; Albertini, D.F. The intracellular movement of endocytic vesicles in cultured granulosa cells. Cell Motil. 1982, 2, 583–597. [Google Scholar] [CrossRef]
  100. Potokar, M.; Kreft, M.; Li, L.; Daniel Andersson, J.; Pangrsic, T.; Chowdhury, H.H.; Pekny, M.; Zorec, R. Cytoskeleton and vesicle mobility in astrocytes. Traffic 2007, 8, 12–20. [Google Scholar] [CrossRef]
  101. Styers, M.L.; Kowalczyk, A.P.; Faundez, V. Intermediate filaments and vesicular membrane traffic: the odd couple's first dance? Traffic 2005, 6, 359–365. [Google Scholar] [CrossRef]
  102. Akula, S.M.; Naranatt, P.P.; Walia, N.S.; Wang, F.Z.; Fegley, B.; Chandran, B. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J. Virol. 2003, 77, 7978–7990. [Google Scholar] [CrossRef]
  103. Styers, M.L.; Salazar, G.; Love, R.; Peden, A.A.; Kowalczyk, A.P.; Faundez, V. The endo-lysosomal sorting machinery interacts with the intermediate filament cytoskeleton. Mol. Biol. Cell 2004, 15, 5369–5382. [Google Scholar] [CrossRef]
  104. Robinson, M.S. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004, 14, 167–174. [Google Scholar] [CrossRef]
  105. Kantheti, P.; Qiao, X.; Diaz, M.E.; Peden, A.A.; Meyer, G.E.; Carskadon, S.L.; Kapfhamer, D.; Sufalko, D.; Robinson, M.S.; Noebels, J.L.; et al. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 1998, 21, 111–122. [Google Scholar] [CrossRef]
  106. Salazar, G.; Love, R.; Styers, M.L.; Werner, E.; Peden, A.; Rodriguez, S.; Gearing, M.; Wainer, B.H.; Faundez, V. AP-3-dependent mechanisms control the targeting of a chloride channel (ClC-3) in neuronal and non-neuronal cells. J. Biol. Chem. 2004, 279, 25430–25439. [Google Scholar] [CrossRef]
  107. Li, X.; Wang, T.; Zhao, Z.; Weinman, S.A. The ClC-3 chloride channel promotes acidification of lysosomes in CHO-K1 and Huh-7 cells. Am. J. Physiol. Cell Physiol. 2002, 282, C1483–C1491. [Google Scholar] [CrossRef] [PubMed]
  108. Matsuda, J.J.; Filali, M.S.; Collins, M.M.; Volk, K.A.; Lamb, F.S. The ClC-3 Cl-/H+ antiporter becomes uncoupled at low extracellular pH. J. Biol. Chem. 2010, 285, 2569–2579. [Google Scholar] [CrossRef] [PubMed]
  109. Inoue, N.; Winter, J.; Lal, R.B.; Offermann, M.K.; Koyano, S. Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. J. Virol. 2003, 77, 8147–8152. [Google Scholar] [CrossRef] [PubMed]
  110. Nemerow, G.R.; Cooper, N.R. Early events in the infection of human B lymphocytes by Epstein-Barr virus: The internalization process. Virology 1984, 132, 186–198. [Google Scholar] [CrossRef]
  111. Seglen, P.O.; Berg, T.O.; Blankson, H.; Fengsrud, M.; Holen, I.; Stromhaug, P.E. Structural aspects of autophagy. Adv. Exp. Med. Biol. 1996, 389, 103–111. [Google Scholar]
  112. Lee, D.Y.; Lee, J.; Sugden, B. The unfolded protein response and autophagy: Herpesviruses rule! J. Virol. 2009, 83, 1168–1172. [Google Scholar] [CrossRef]
  113. Lyman, M.G.; Enquist, L.W. Herpesvirus interactions with the host cytoskeleton. J. Virol. 2009, 83, 2058–2066. [Google Scholar] [CrossRef]
  114. Welte, M.A. Bidirectional transport along microtubules. Curr. Biol. 2004, 14, R525–R537. [Google Scholar] [CrossRef]
  115. Salpingidou, G.; Smertenko, A.; Hausmanowa-Petrucewicz, I.; Hussey, P.J.; Hutchison, C.J. A novel role for the nuclear membrane protein emerin in association of the centrosome to the outer nuclear membrane. J. Cell Biol. 2007, 178, 897–904. [Google Scholar] [CrossRef]
  116. Renaud, J.; Kerjan, G.; Sumita, I.; Zagar, Y.; Georget, V.; Kim, D.; Fouquet, C.; Suda, K.; Sanbo, M.; Suto, F.; et al. Plexin-A2 and its ligand, Sema6A, control nucleus-centrosome coupling in migrating granule cells. Nat. Neurosci. 2008, 11, 440–449. [Google Scholar] [CrossRef]
  117. Sodeik, B.; Ebersold, M.W.; Helenius, A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 1997, 136, 1007–1021. [Google Scholar] [CrossRef]
  118. Peng, L.; Ryazantsev, S.; Sun, R.; Zhou, Z.H. Three-dimensional visualization of gammaherpesvirus life cycle in host cells by electron tomography. Structure 2010, 18, 47–58. [Google Scholar] [CrossRef]
  119. Ojala, P.M.; Sodeik, B.; Ebersold, M.W.; Kutay, U.; Helenius, A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell Biol. 2000, 20, 4922–4931. [Google Scholar] [CrossRef]
  120. Shahin, V.; Hafezi, W.; Oberleithner, H.; Ludwig, Y.; Windoffer, B.; Schillers, H.; Kuhn, J.E. The genome of HSV-1 translocates through the nuclear pore as a condensed rod-like structure. J. Cell Sci. 2006, 119, 23–30. [Google Scholar] [CrossRef]
  121. Copeland, A.M.; Newcomb, W.W.; Brown, J.C. Herpes simplex virus replication: Roles of viral proteins and nucleoporins in capsid-nucleus attachment. J. Virol. 2009, 83, 1660–1668. [Google Scholar] [CrossRef]
  122. Djabali, K.; Portier, M.M.; Gros, F.; Blobel, G.; Georgatos, S.D. Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments. Cell 1991, 64, 109–121. [Google Scholar] [CrossRef]
  123. Georgatos, S.D.; Blobel, G. Lamin B constitutes an intermediate filament attachment site at the nuclear envelope. J. Cell Biol. 1987, 105, 117–125. [Google Scholar] [CrossRef]
  124. Georgatos, S.D.; Weber, K.; Geisler, N.; Blobel, G. Binding of two desmin derivatives to the plasma membrane and the nuclear envelope of avian erythrocytes: evidence for a conserved site-specificity in intermediate filament-membrane interactions. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 6780–6784. [Google Scholar] [CrossRef]
  125. Capco, D.G.; Wan, K.M.; Penman, S. The nuclear matrix: Three-dimensional architecture and protein composition. Cell 1982, 29, 847–858. [Google Scholar] [CrossRef]
  126. Katsuma, Y.; Swierenga, S.H.; Marceau, N.; French, S.W. Connections of intermediate filaments with the nuclear lamina and the cell periphery. Biol. Cell 1987, 59, 193–203. [Google Scholar] [CrossRef]
  127. Carmo-Fonseca, M.; Cidadao, A.J.; David-Ferreira, J.F. Filamentous cross-bridges link intermediate filaments to the nuclear pore complexes. Eur. J. Cell Biol. 1988, 45, 282–290. [Google Scholar] [PubMed]
  128. French, S.W.; Kawahara, H.; Katsuma, Y.; Ohta, M.; Swierenga, S.H. Interaction of intermediate filaments with nuclear lamina and cell periphery. Electron. Microsc. Rev. 1989, 2, 17–51. [Google Scholar] [CrossRef] [PubMed]
  129. Starr, D.A. Communication between the cytoskeleton and the nuclear envelope to position the nucleus. Mol. Biosyst. 2007, 3, 583–589. [Google Scholar] [CrossRef] [PubMed]
  130. Starr, D.A.; Fridolfsson, H.N. Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges. Annu. Rev. Cell Dev. Biol. 2010, 26, 421–444. [Google Scholar] [CrossRef] [PubMed]
  131. Maniotis, A.J.; Chen, C.S.; Ingber, D.E. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 849–854. [Google Scholar] [CrossRef]
  132. Traub, P. Intermediate filaments and gene regulation. Physiol. Chem. Phys. Med. NMR 1995, 27, 377–400. [Google Scholar]
  133. Shaklai, S.; Amariglio, N.; Rechavi, G.; Simon, A.J. Gene silencing at the nuclear periphery. FEBS J. 2007, 274, 1383–1392. [Google Scholar] [CrossRef]
  134. Lee, D.C.; Welton, K.L.; Smith, E.D.; Kennedy, B.K. A-type nuclear lamins act as transcriptional repressors when targeted to promoters. Exp. Cell Res. 2009, 315, 996–1007. [Google Scholar] [CrossRef]
  135. Somech, R.; Shaklai, S.; Geller, O.; Amariglio, N.; Simon, A.J.; Rechavi, G.; Gal-Yam, E.N. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. J. Cell Sci. 2005, 118, 4017–4025. [Google Scholar] [CrossRef]
  136. Polioudaki, H.; Kourmouli, N.; Drosou, V.; Bakou, A.; Theodoropoulos, P.A.; Singh, P.B.; Giannakouros, T.; Georgatos, S.D. Histones H3/H4 form a tight complex with the inner nuclear membrane protein LBR and heterochromatin protein 1. EMBO Rep. 2001, 2, 920–925. [Google Scholar] [CrossRef]
  137. Paulus, C.; Nitzsche, A.; Nevels, M. Chromatinisation of herpesvirus genomes. Rev. Med. Virol. 2010, 20, 34–50. [Google Scholar] [CrossRef]
  138. Silva, L.; Cliffe, A.; Chang, L.; Knipe, D.M. Role for A-type lamins in herpesviral DNA targeting and heterochromatin modulation. PLoS Pathog. 2008, 4, e1000071. [Google Scholar] [CrossRef]
  139. Zhou, Q.; Ji, X.; Chen, L.; Greenberg, H.B.; Lu, S.C.; Omary, M.B. Keratin mutation primes mouse liver to oxidative injury. Hepatology 2005, 41, 517–525. [Google Scholar] [CrossRef]
  140. Hagemann, T.L.; Gaeta, S.A.; Smith, M.A.; Johnson, D.A.; Johnson, J.A.; Messing, A. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum. Mol. Genet. 2005, 14, 2443–2458. [Google Scholar] [CrossRef]
  141. Li, H.; Choudhary, S.K.; Milner, D.J.; Munir, M.I.; Kuisk, I.R.; Capetanaki, Y. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J. Cell Biol. 1994, 124, 827–841. [Google Scholar] [CrossRef]
  142. Jones, J.O.; Arvin, A.M. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J. Virol. 2003, 77, 1268–1280. [Google Scholar] [CrossRef]
  143. Hertel, L.; Lacaille, V.G.; Strobl, H.; Mellins, E.D.; Mocarski, E.S. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 2003, 77, 7563–7574. [Google Scholar] [CrossRef]
  144. Luo, M.H.; Hannemann, H.; Kulkarni, A.S.; Schwartz, P.H.; O'Dowd, J.M.; Fortunato, E.A. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J. Virol. 2010, 84, 3528–3541. [Google Scholar] [CrossRef]
  145. Cornelissen, M.; van der Kuyl, A.C.; van den Burg, R.; Zorgdrager, F.; van Noesel, C.J.; Goudsmit, J. Gene expression profile of AIDS-related Kaposi's sarcoma. BMC Cancer 2003, 3, 7. [Google Scholar] [CrossRef]
  146. Uozaki, H.; Chong, J.M.; Fujimoto, E.; Itoh, M.; Saito, M.; Sakuma, K.; Sudo, M.; Ushiku, T.; Niki, T.; Nagai, H.; et al. Soft and hard keratin expression in Epstein-Barr-virus-associated gastric carcinoma. Anticancer Res. 2005, 25, 3183–3190. [Google Scholar]
  147. Nishikawa, J.; Kiss, C.; Imai, S.; Takada, K.; Okita, K.; Klein, G.; Szekely, L. Upregulation of the truncated basic hair keratin 1(hHb1-DeltaN) in carcinoma cells by Epstein-Barr virus (EBV). Int. J. Cancer 2003, 107, 597–602. [Google Scholar] [CrossRef] [PubMed]
  148. Birkenbach, M.; Liebowitz, D.; Wang, F.; Sample, J.; Kieff, E. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J. Virol. 1989, 63, 4079–4084. [Google Scholar] [CrossRef] [PubMed]
  149. Allday, M.J.; Crawford, D.H.; Thomas, J.A. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J. Gen. Virol. 1993, 74, 361–369. [Google Scholar] [CrossRef] [PubMed]
  150. Silins, S.L.; Sculley, T.B. Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4. Virology 1994, 202, 16–24. [Google Scholar] [CrossRef] [PubMed]
  151. Ray, N.; Enquist, L.W. Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesviruses. J. Virol. 2004, 78, 3489–3501. [Google Scholar] [CrossRef]
  152. Taddeo, B.; Esclatine, A.; Roizman, B. The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 17031–17036. [Google Scholar] [CrossRef]
  153. Mettenleiter, T.C.; Klupp, B.G.; Granzow, H. Herpesvirus assembly: An update. Virus Res. 2009, 143, 222–234. [Google Scholar] [CrossRef]
  154. Lee, C.P.; Chen, M.R. Escape of herpesviruses from the nucleus. Rev. Med. Virol. 2010, 20, 214–230. [Google Scholar] [CrossRef]
  155. Britt, B. Maturation and egress. In Human Herpesviruses: Biology, Therapy and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007. [Google Scholar]
  156. Prokocimer, M.; Davidovich, M.; Nissim-Rafinia, M.; Wiesel-Motiuk, N.; Bar, D.; Barkan, R.; Meshorer, E.; Gruenbaum, Y. Nuclear lamins: Key regulators of nuclear structure and activities. J. Cell. Mol. Med. 2009, 13, 1059–1085. [Google Scholar] [CrossRef]
  157. Scott, E.S.; O'Hare, P. Fate of the inner nuclear membrane protein lamin B receptor and nuclear lamins in herpes simplex virus type 1 infection. J. Virol. 2001, 75, 8818–8830. [Google Scholar] [CrossRef]
  158. Park, R.; Baines, J.D. Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J. Virol. 2006, 80, 494–504. [Google Scholar] [CrossRef]
  159. Reynolds, A.E.; Liang, L.; Baines, J.D. Conformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34. J. Virol. 2004, 78, 5564–5575. [Google Scholar] [CrossRef]
  160. Simpson-Holley, M.; Baines, J.; Roller, R.; Knipe, D.M. Herpes simplex virus 1 U(L)31 and U(L)34 gene products promote the late maturation of viral replication compartments to the nuclear periphery. J. Virol. 2004, 78, 5591–5600. [Google Scholar] [CrossRef]
  161. Morris, J.B.; Hofemeister, H.; O'Hare, P. Herpes simplex virus infection induces phosphorylation and delocalization of emerin, a key inner nuclear membrane protein. J. Virol. 2007, 81, 4429–4437. [Google Scholar] [CrossRef]
  162. Leach, N.; Bjerke, S.L.; Christensen, D.K.; Bouchard, J.M.; Mou, F.; Park, R.; Baines, J.; Haraguchi, T.; Roller, R.J. Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. J. Virol. 2007, 81, 10792–10803. [Google Scholar] [CrossRef]
  163. Mou, F.; Forest, T.; Baines, J.D. US3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J. Virol. 2007, 81, 6459–6470. [Google Scholar] [CrossRef]
  164. Cano-Monreal, G.L.; Wylie, K.M.; Cao, F.; Tavis, J.E.; Morrison, L.A. Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins. Virology 2009, 392, 137–147. [Google Scholar] [CrossRef]
  165. Yamauchi, Y.; Shiba, C.; Goshima, F.; Nawa, A.; Murata, T.; Nishiyama, Y. Herpes simplex virus type 2 UL34 protein requires UL31 protein for its relocation to the internal nuclear membrane in transfected cells. J. Gen. Virol. 2001, 82, 1423–1428. [Google Scholar] [CrossRef]
  166. Simpson-Holley, M.; Colgrove, R.C.; Nalepa, G.; Harper, J.W.; Knipe, D.M. Identification and functional evaluation of cellular and viral factors involved in the alteration of nuclear architecture during herpes simplex virus 1 infection. J. Virol. 2005, 79, 12840–12851. [Google Scholar] [CrossRef]
  167. Bjerke, S.L.; Roller, R.J. Roles for herpes simplex virus type 1 UL34 and US3 proteins in disrupting the nuclear lamina during herpes simplex virus type 1 egress. Virology 2006, 347, 261–276. [Google Scholar] [CrossRef]
  168. Kato, A.; Yamamoto, M.; Ohno, T.; Tanaka, M.; Sata, T.; Nishiyama, Y.; Kawaguchi, Y. Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J. Virol. 2006, 80, 1476–1486. [Google Scholar] [CrossRef] [PubMed]
  169. Leach, N.R.; Roller, R.J. Significance of host cell kinases in herpes simplex virus type 1 egress and lamin-associated protein disassembly from the nuclear lamina. Virology 2010, 406, 127–137. [Google Scholar] [CrossRef] [PubMed]
  170. Mou, F.; Wills, E.G.; Park, R.; Baines, J.D. Effects of lamin A/C, lamin B1, and viral US3 kinase activity on viral infectivity, virion egress, and the targeting of herpes simplex virus U(L)34-encoded protein to the inner nuclear membrane. J. Virol. 2008, 82, 8094–8104. [Google Scholar] [CrossRef] [PubMed]
  171. Schirmer, E.C.; Foisner, R. Proteins that associate with lamins: Many faces, many functions. Exp. Cell Res. 2007, 313, 2167–2179. [Google Scholar] [CrossRef]
  172. Dechat, T.; Pfleghaar, K.; Sengupta, K.; Shimi, T.; Shumaker, D.K.; Solimando, L.; Goldman, R.D. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 2008, 22, 832–853. [Google Scholar] [CrossRef]
  173. Wild, P.; Engels, M.; Senn, C.; Tobler, K.; Ziegler, U.; Schraner, E.M.; Loepfe, E.; Ackermann, M.; Mueller, M.; Walther, P. Impairment of nuclear pores in bovine herpesvirus 1-infected MDBK cells. J. Virol. 2005, 79, 1071–1083. [Google Scholar] [CrossRef]
  174. Ruebner, B.H.; Miyai, K.; Slusser, R.J.; Wedemeyer, P.; Medearis, D.N., Jr. Mouse cytomegalovirus infection. An electron microscopic study of hepatic parenchymal cells. Am. J. Pathol. 1964, 44, 799–821. [Google Scholar]
  175. Papadimitriou, J.M.; Shellam, G.R.; Robertson, T.A. An ultrastructural investigation of cytomegalovirus replication in murine hepatocytes. J. Gen. Virol. 1984, 65, 1979–1990. [Google Scholar] [CrossRef]
  176. Gilloteaux, J.; Nassiri, M.R. Human bone marrow fibroblasts infected by cytomegalovirus: ultrastructural observations. J. Submicrosc. Cytol. Pathol. 2000, 32, 17–45. [Google Scholar]
  177. Severi, B.; Landini, M.P.; Govoni, E. Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Arch. Virol. 1988, 98, 51–64. [Google Scholar] [CrossRef]
  178. Buser, C.; Walther, P.; Mertens, T.; Michel, D. Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane. J. Virol. 2007, 81, 3042–3048. [Google Scholar] [CrossRef]
  179. Muranyi, W.; Haas, J.; Wagner, M.; Krohne, G.; Koszinowski, U.H. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 2002, 297, 854–857. [Google Scholar] [CrossRef]
  180. Milbradt, J.; Auerochs, S.; Sticht, H.; Marschall, M. Cytomegaloviral proteins that associate with the nuclear lamina: Components of a postulated nuclear egress complex. J. Gen. Virol. 2009, 90, 579–590. [Google Scholar] [CrossRef]
  181. Milbradt, J.; Webel, R.; Auerochs, S.; Sticht, H.; Marschall, M. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J. Biol. Chem. 2010, 285, 13979–13989. [Google Scholar] [CrossRef]
  182. Marschall, M.; Marzi, A.; aus dem Siepen, P.; Jochmann, R.; Kalmer, M.; Auerochs, S.; Lischka, P.; Leis, M.; Stamminger, T. Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J. Biol. Chem. 2005, 280, 33357–33367. [Google Scholar] [CrossRef]
  183. Radsak, K.; Schneider, D.; Jost, E.; Brucher, K.H. Alteration of nuclear lamina protein in human fibroblasts infected with cytomegalovirus (HCMV). Arch. Virol. 1989, 105, 103–112. [Google Scholar] [CrossRef]
  184. Camozzi, D.; Pignatelli, S.; Valvo, C.; Lattanzi, G.; Capanni, C.; Dal Monte, P.; Landini, M.P. Remodelling of the nuclear lamina during human cytomegalovirus infection: Role of the viral proteins pUL50 and pUL53. J. Gen. Virol. 2008, 89, 731–740. [Google Scholar] [CrossRef]
  185. Hamirally, S.; Kamil, J.P.; Ndassa-Colday, Y.M.; Lin, A.J.; Jahng, W.J.; Baek, M.C.; Noton, S.; Silva, L.A.; Simpson-Holley, M.; Knipe, D.M.; et al. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 2009, 5, e1000275. [Google Scholar] [CrossRef]
  186. Milbradt, J.; Auerochs, S.; Marschall, M. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J. Gen. Virol. 2007, 88, 2642–2650. [Google Scholar] [CrossRef]
  187. Prichard, M.N. Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev. Med. Virol. 2009, 19, 215–229. [Google Scholar] [CrossRef]
  188. Kawaguchi, Y.; Kato, K. Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2. Rev. Med. Virol. 2003, 13, 331–340. [Google Scholar] [CrossRef] [PubMed]
  189. Peter, M.; Nakagawa, J.; Doree, M.; Labbe, J.C.; Nigg, E.A. In vitro disassembly of the nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinase. Cell 1990, 61, 591–602. [Google Scholar] [CrossRef] [PubMed]
  190. Hertel, L.; Mocarski, E.S. Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function. J. Virol. 2004, 78, 11988–12011. [Google Scholar] [CrossRef] [PubMed]
  191. Hertel, L.; Chou, S.; Mocarski, E.S. Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog. 2007, 3, e6. [Google Scholar] [CrossRef]
  192. Torrisi, M.R.; Cirone, M.; Pavan, A.; Zompetta, C.; Barile, G.; Frati, L.; Faggioni, A. Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J. Virol. 1989, 63, 828–832. [Google Scholar] [CrossRef]
  193. Farina, A.; Santarelli, R.; Gonnella, R.; Bei, R.; Muraro, R.; Cardinali, G.; Uccini, S.; Ragona, G.; Frati, L.; Faggioni, A.; et al. The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J. Virol. 2000, 74, 3235–3244. [Google Scholar] [CrossRef]
  194. Farina, A.; Feederle, R.; Raffa, S.; Gonnella, R.; Santarelli, R.; Frati, L.; Angeloni, A.; Torrisi, M.R.; Faggioni, A.; Delecluse, H.J. BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J. Virol. 2005, 79, 3703–3712. [Google Scholar] [CrossRef]
  195. Gonnella, R.; Farina, A.; Santarelli, R.; Raffa, S.; Feederle, R.; Bei, R.; Granato, M.; Modesti, A.; Frati, L.; Delecluse, H.J.; et al. Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: Interactions with BFRF1 and with the nuclear lamina. J. Virol. 2005, 79, 3713–3727. [Google Scholar] [CrossRef]
  196. Lee, C.P.; Huang, Y.H.; Lin, S.F.; Chang, Y.; Chang, Y.H.; Takada, K.; Chen, M.R. Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J. Virol. 2008, 82, 11913–11926. [Google Scholar] [CrossRef]
  197. Norregard Nielsen, L.; Forchhammer, J.; Dabelsteen, E.; Jepsen, A.; Stubbe Teglbjaerg, C.; Norrild, B. Herpes simplex virus-induced changes of the keratin type intermediate filament in rat epithelial cells. J. Gen. Virol. 1987, 68, 737–748. [Google Scholar] [CrossRef]
  198. Murata, T.; Goshima, F.; Nishizawa, Y.; Daikoku, T.; Takakuwa, H.; Ohtsuka, K.; Yoshikawa, T.; Nishiyama, Y. Phosphorylation of cytokeratin 17 by herpes simplex virus type 2 US3 protein kinase. Microbiol. Immunol. 2002, 46, 707–719. [Google Scholar] [CrossRef]
  199. Linden, M.; Li, Z.; Paulin, D.; Gotow, T.; Leterrier, J.F. Effects of desmin gene knockout on mice heart mitochondria. J. Bioenerg. Biomembr. 2001, 33, 333–341. [Google Scholar] [CrossRef]
  200. Milner, D.J.; Mavroidis, M.; Weisleder, N.; Capetanaki, Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J. Cell Biol. 2000, 150, 1283–1298. [Google Scholar] [CrossRef]
  201. Brownlees, J.; Ackerley, S.; Grierson, A.J.; Jacobsen, N.J.; Shea, K.; Anderton, B.H.; Leigh, P.N.; Shaw, C.E.; Miller, C.C. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 2002, 11, 2837–2844. [Google Scholar] [CrossRef]
  202. Magin, T.M.; Vijayaraj, P.; Leube, R.E. Structural and regulatory functions of keratins. Exp. Cell Res. 2007, 313, 2021–2032. [Google Scholar] [CrossRef]
  203. Labudova, M.; Tomaskova, J.; Skultety, L.; Pastorek, J.; Pastorekova, S. The nucleoprotein of lymphocytic choriomeningitis virus facilitates spread of persistent infection through stabilization of the keratin network. J. Virol. 2009, 83, 7842–7849. [Google Scholar] [CrossRef]
Figure 1. Steps during herpesvirus entry that may require intermediate filaments’ assistance for efficient completion. IF and microtubules are shown as three parallel thin red lines and as thick blue lines, respectively. Black hexagons enclosed in a circle depict enveloped virions, while isolated black hexagons represent virus capsids. (A) Keratin-type IF potentially strengthening initial virion interactions with the cell surface; (B) enhancement of capsid attachment to microtubules via IF; (C) internalization of integrin-bound virions under the control of IF; (D) endosomes trafficking towards the cell center accompanied by IF; (E) AP-3 mediated endosome acidification and viral particles release facilitated by IF; (F) capsid movement along the nuclear envelope towards the nuclear pore complex assisted by IF; and (G) regulation of viral gene transcription onset by nuclear IF. MTOC, microtubule organizing center.
Figure 1. Steps during herpesvirus entry that may require intermediate filaments’ assistance for efficient completion. IF and microtubules are shown as three parallel thin red lines and as thick blue lines, respectively. Black hexagons enclosed in a circle depict enveloped virions, while isolated black hexagons represent virus capsids. (A) Keratin-type IF potentially strengthening initial virion interactions with the cell surface; (B) enhancement of capsid attachment to microtubules via IF; (C) internalization of integrin-bound virions under the control of IF; (D) endosomes trafficking towards the cell center accompanied by IF; (E) AP-3 mediated endosome acidification and viral particles release facilitated by IF; (F) capsid movement along the nuclear envelope towards the nuclear pore complex assisted by IF; and (G) regulation of viral gene transcription onset by nuclear IF. MTOC, microtubule organizing center.
Viruses 03 01015 g001
Figure 2. Herpes simplex virus 1 (HSV-1), cytomegalovirus (CMV) and Epstein-Barr virus (EBV) nuclear egress complex components and their interactions with the nuclear lamina. The two brown and thick lines represent the nuclear envelope, while the short black thin lines depict the lamin A/C and lamin B proteins comprising the nuclear lamina. Asterisks represent phosphorylation events performed by kinase proteins, whose names are contained in yellow-colored circles or ovals linked to the asterisks by orange arrows or arrowheads. The names of the two viral proteins composing the core of each nuclear egress complex (NEC) are contained within red- or orange-colored circles.
Figure 2. Herpes simplex virus 1 (HSV-1), cytomegalovirus (CMV) and Epstein-Barr virus (EBV) nuclear egress complex components and their interactions with the nuclear lamina. The two brown and thick lines represent the nuclear envelope, while the short black thin lines depict the lamin A/C and lamin B proteins comprising the nuclear lamina. Asterisks represent phosphorylation events performed by kinase proteins, whose names are contained in yellow-colored circles or ovals linked to the asterisks by orange arrows or arrowheads. The names of the two viral proteins composing the core of each nuclear egress complex (NEC) are contained within red- or orange-colored circles.
Viruses 03 01015 g002
Table 1. Identity, tissue distribution and intracellular localization of intermediate filament (IF) family members.
Table 1. Identity, tissue distribution and intracellular localization of intermediate filament (IF) family members.
TypeProtein NameCell TypeTissue Type
IAcidic keratins:
K9-K28
K31-K40
Epithelial cells, keratinocytesMucosae, epidermis
Hair, epidermal appendages
IIBasic keratins:
K1-8, K71-80
K81-86
Epithelial cells, keratinocytesMucosae, epidermis
Hair, epidermal appendages
IIIVimentin

Peripherin
Glial fibrillary acidic protein
Syncoilin
Desmin
Mesenchymal cells: fibroblasts, endothelial, hematopoietic cells
Neuronal cells
Astrocytes and glia
Muscle cells
Connective tissue, blood, blood vessels
Nervous system
Nervous system
Muscles
IVα-internexin
Neurofilament H, L, and M
Nestin
Synemin α, synemin β
Neuronal cells
Neuronal cells
Neuroepithelial cells
Muscle cells
Nervous system
Nervous system
Nervous system
Muscles
VLamin A, B1, B2, C1, C2UbiquitousUbiquitous
VICP49/phakinin, filensin/CP115Eye lens cellsEye lens
Table 2. Human herpesviruses and permissive cell types.
Table 2. Human herpesviruses and permissive cell types.
SubfamilyVirus NameProductive InfectionLatency
AlphaHSV-1Epithelial cells, neuronsNeurons: trigeminal ganglia
HSV-2
VZVEpithelial cells, neurons, monocytes, dendritic cells, T and B lymphocytesNeurons: dorsal root ganglia
BetaCMVMost cell types except lymphocytes, eosinophils, basophils, and neutrophilsMyeloid progenitors
HHV-6CD4+ T cells, neurons, astrocytes, microglia, fibroblasts, epithelial, endothelial and dendritic cellsLymphocytes, Monocyte/macrophages, other?
HHV-7CD4+ T cells
GammaEBVB and T cells, dendritic, NK and smooth muscle cellsMemory B cells
KSHVB cells, endothelial cells, epithelial cells, keratinocytes and fibroblasts
Table 3. Changes in expression levels of IF-encoding genes as reported in functional genomics analyses of infected human tissues and fibroblasts (HF).
Table 3. Changes in expression levels of IF-encoding genes as reported in functional genomics analyses of infected human tissues and fibroblasts (HF).
Gene NameGene SymbolVZV in T Cells *VZV in Skin *VZV in HF *HSV in HF &CMV in HF @
Keratin 1
Keratin 5
Keratin 6A
Keratin 8
Keratin 13
Keratin 17
Keratin 18
Keratin 19
Keratin 33A
Keratin 71
Keratin 85
Keratin 86
KRT1
KRT5
KRT6A
KRT8
KRT13
KRT17
KRT18
KRT19
KRT33A
KRT71
KRT85
KRT86
-
-
-
-
-
-
-
-
UP
-
-
-
DOWN
DOWN
DOWN
-
-
DOWN
-
UP
-
DOWN
-
-
-
-
UP
-
-
-
-
-
-
-
-
-
-
-
-
UP
-
-
UP
-
-
-
-
-
-
UP
-
-
UP
-
UP
DOWN
-
-
UP
UP
Desmin
Peripherin
Syncoilin
Vimentin
DES
PRPH
SYNC
VIM
-
-
UP
-
UP
-
-
UP
-
-
-
-
-
UP
-
DOWN
-
-
DOWN
DOWN
Neurofilament 3
Neurofilament heavy
NEF3
NEFH
-
DOWN
DOWN
-
-
-
-
-
UP
-
Lamin B1LMNB1----UP
Data derived from the following references: * [142]; & [151,152]; @ [143].

Share and Cite

MDPI and ACS Style

Hertel, L. Herpesviruses and Intermediate Filaments: Close Encounters with the Third Type. Viruses 2011, 3, 1015-1040. https://doi.org/10.3390/v3071015

AMA Style

Hertel L. Herpesviruses and Intermediate Filaments: Close Encounters with the Third Type. Viruses. 2011; 3(7):1015-1040. https://doi.org/10.3390/v3071015

Chicago/Turabian Style

Hertel, Laura. 2011. "Herpesviruses and Intermediate Filaments: Close Encounters with the Third Type" Viruses 3, no. 7: 1015-1040. https://doi.org/10.3390/v3071015

APA Style

Hertel, L. (2011). Herpesviruses and Intermediate Filaments: Close Encounters with the Third Type. Viruses, 3(7), 1015-1040. https://doi.org/10.3390/v3071015

Article Metrics

Back to TopTop